The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis
- Resource Type
- Article
- Source
- In
Brain Behavior and Immunity January 2014 35:176-181 - Subject
- Language
- ISSN
- 0889-1591